AAAAAA

   
Results: 1-16 |
Results: 16
Triple-negative (CD3(-)/CD4(-)/CD8(-)) adult T cell leukemia/lymphoma, histologically presenting as CD30 (Ki-1)-positive anaplastic large cell lymphoma with clonal Epstein-Barr virus genome
Authors: Kumura, T Hino, M Yamane, T Ohta, K Nakao, T Wakasa, K Tatsumi, N
Citation: T. Kumura et al., Triple-negative (CD3(-)/CD4(-)/CD8(-)) adult T cell leukemia/lymphoma, histologically presenting as CD30 (Ki-1)-positive anaplastic large cell lymphoma with clonal Epstein-Barr virus genome, LEUKEMIA, 15(6), 2001, pp. 994-995
Expression of KL-6 antigen on leukemia cells of a patient with chronic myelocytic leukemia in blastic phase
Authors: Takubo, T Fujino, H Hino, M Yamane, T Ohta, K Koh, KR Kumura, T Hashimoto, S Nakao, T Nakamae, H Aoyama, Y Nishiki, S Kinoshita, Y Kamitani, T Tatsumi, N Hojo, S Fujita, J
Citation: T. Takubo et al., Expression of KL-6 antigen on leukemia cells of a patient with chronic myelocytic leukemia in blastic phase, HAEMATOLOGI, 31(2), 2001, pp. 173-176
Elevation of serum procalcitonin level in a patient with chronic myelocytic leukemia
Authors: Takubo, T Kumura, T Ohta, K Yamane, T Hino, M Kamitani, T Tatsumi, N
Citation: T. Takubo et al., Elevation of serum procalcitonin level in a patient with chronic myelocytic leukemia, HAEMATOLOGI, 31(2), 2001, pp. 177-179
Serum KL-6 levels in haematologic malignancies and their clinical application
Authors: Takubo, T Kumura, T Nakao, T Nakamae, H Aoyama, Y Nishiki, S Kinoshita, Y Koh, KR Ohta, K Yamane, T Hino, M Kamitani, T Tatsumi, N
Citation: T. Takubo et al., Serum KL-6 levels in haematologic malignancies and their clinical application, HAEMATOLOGI, 31(1), 2001, pp. 61-67
Expression of human interleukin-18 antigen in leukemia cells of a patient with acute mixed lineage leukemia
Authors: Takubo, T Kumura, T Nakao, T Nakamae, H Aoyama, Y Kinoshita, Y Koh, KR Ohta, K Yamane, T Hino, M Kamitani, T Tatsumi, N
Citation: T. Takubo et al., Expression of human interleukin-18 antigen in leukemia cells of a patient with acute mixed lineage leukemia, HAEMATOLOGI, 31(1), 2001, pp. 69-71
Hirudin as an anticoagulant for both haematology and chemistry tests
Authors: Kumura, T Hino, M Yamane, T Tatsumi, N
Citation: T. Kumura et al., Hirudin as an anticoagulant for both haematology and chemistry tests, J AUTOM M M, 22(4), 2000, pp. 109-112
Convergence performance of adaptive lattice filters with nonlinear parameter updates
Authors: Kumura, T Iiguni, Y Maeda, H
Citation: T. Kumura et al., Convergence performance of adaptive lattice filters with nonlinear parameter updates, IEE P-VIS I, 147(3), 2000, pp. 238-246
A case of rhabdomyolysis due to levofloxacin
Authors: Nakamae, H Hino, M Yamane, T Ohta, K Aoyama, Y Kumura, T Sannomiya, Y Tatsumi, N
Citation: H. Nakamae et al., A case of rhabdomyolysis due to levofloxacin, CLIN DRUG I, 20(3), 2000, pp. 203-205
Argatroban as an anticoagulant for both hematologic and chemical tests
Authors: Kumura, T Hino, M Yamane, T Tatsumi, N
Citation: T. Kumura et al., Argatroban as an anticoagulant for both hematologic and chemical tests, J CL LAB AN, 14(4), 2000, pp. 136-140
Lymphoma in Castleman's disease, acute lymphocytic leukemia, adult T-cell leukemia and cutaneous T-cell lymphoma accompanied with high serum soluble Fas ligand levels
Authors: Takubo, T Ohkura, H Kumura, T Ohta, K Yamane, T Hino, M Kamitani, T Tatsumi, N
Citation: T. Takubo et al., Lymphoma in Castleman's disease, acute lymphocytic leukemia, adult T-cell leukemia and cutaneous T-cell lymphoma accompanied with high serum soluble Fas ligand levels, HAEMATOLOGI, 30(1), 2000, pp. 23-26
Serum IL-18 levels in patients with various hematological disorders
Authors: Takubo, T Ohkura, H Kumura, T Ohta, K Yamane, T Hino, M Kamitani, T Tatsumi, I
Citation: T. Takubo et al., Serum IL-18 levels in patients with various hematological disorders, HAEMATOLOGI, 30(1), 2000, pp. 31-33
DX-9065a, a specific factor Xa inhibitor, as a universal anticoagulant forblood collection tubes
Authors: Kumura, T Hino, M Yamane, T Tominaga, K Tatsumi, N
Citation: T. Kumura et al., DX-9065a, a specific factor Xa inhibitor, as a universal anticoagulant forblood collection tubes, CLIN CHIM A, 294(1-2), 2000, pp. 27-35
Comparative study on complete remission rate and overall survival in threegroups classified based on the serum interleukin-18 level in non-Hodgkin'slymphoma patients
Authors: Takubo, T Kumura, T Nakao, T Nakamae, H Aoyama, Y Nishiki, S Kinoshita, Y Koh, KR Ohta, K Yamane, T Hino, M Kamitani, T Tatsumi, N
Citation: T. Takubo et al., Comparative study on complete remission rate and overall survival in threegroups classified based on the serum interleukin-18 level in non-Hodgkin'slymphoma patients, ACT HAEMAT, 104(4), 2000, pp. 220-222
Clinical usefulness of combined measurements of serum soluble transferrin receptor levels and serum interleukin-18 levels at determination of serum KL-6 levels in haematologic malignancies
Authors: Takubo, T Kumura, T Nakao, T Nakamae, H Aoyama, Y Nishiki, S Kinoshita, Y Koh, KR Ohta, K Yamane, T Hino, M Kamitani, T Tatsumi, N
Citation: T. Takubo et al., Clinical usefulness of combined measurements of serum soluble transferrin receptor levels and serum interleukin-18 levels at determination of serum KL-6 levels in haematologic malignancies, ACT HAEMAT, 104(2-3), 2000, pp. 141-143
Human IL-18 bioactivity in hematological malignancies with highly elevatedserum IL-18 levels
Authors: Takubo, T Okura, H Kumura, T Nishiki, S Kinoshita, Y Koh, KR Ohta, K Yamane, T Hino, M Kamitani, T Tatsumi, N
Citation: T. Takubo et al., Human IL-18 bioactivity in hematological malignancies with highly elevatedserum IL-18 levels, ACT HAEMAT, 103(3), 2000, pp. 162-164
Clinical significance of simultaneous determination of serum soluble transferrin receptor, soluble fas, soluble fas ligand, hepatocyte growth factor and interleukin 18 levels in a patient with hemophagocytic syndrome
Authors: Takubo, T Kumura, T Nishiki, S Kinoshita, Y Koh, KR Ohta, K Yamane, T Hino, M Kamitani, T Tatsumi, N
Citation: T. Takubo et al., Clinical significance of simultaneous determination of serum soluble transferrin receptor, soluble fas, soluble fas ligand, hepatocyte growth factor and interleukin 18 levels in a patient with hemophagocytic syndrome, ACT HAEMAT, 103(3), 2000, pp. 165-167
Risultati: 1-16 |